Genetic Basis of Rosacea Study (Control)
- Conditions
- Rosacea
- Interventions
- Other: Skin Biopsy
- Registration Number
- NCT02749786
- Lead Sponsor
- Stanford University
- Brief Summary
Rosacea is a common disease characterized by inflammation and vascular abnormalities of the facial skin and ocular surface. It it considered to be a syndrome encompassing various combinations of cutaneous signs including flushing, erythema, telangiectasia, papules, edema, ocular lesions, and rhinophyma. The exact etiology of cutaneous rosacea is unknown but is characterized by persistent vasodilation, increased vascular permeability, and vascular hyper-reactivity of the microcirculation of the central part of the face. The purpose of this study is to develop gene expression profiles of papulopustular rosacea compared to those of normal skin. The investigator hopes to better understand the abnormal gene functions that might contribute to this condition. This understanding may lead to the development of additional and better treatments for rosacea.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Control Group Skin Biopsy Participants who do not have rosacea (control group)
- Primary Outcome Measures
Name Time Method Gene expression profile of papulopustular rosacea compared to normal skin and skin from individuals without rosacea. Up to 2 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stanford Dermatology
🇺🇸Redwood City, California, United States